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ABSTRACT
A rapid emergence from anesthesia combined with an extended duration of adequate analgesia is desired.
Difficulties arise when trying to achieve a rapid emergence and provide adequate analgesia for procedures
associated with moderate post operative pain. We propose to use pharmacokinetic (PK) and pharmacodynamic
(PD) models with optimization techniques to determine anesthetic drugs ratios to improve post-anesthetic
outcomes of emergence and analgesia. We hypothesize that optimized propofol, remifentanil, and fentanyl
administrations will shorten emergence time and extend the period of adequate analgesia during patient recovery.
Anesthesiologists administered a general anesthetic to 21 patients for laparoscopic procedures with propofol,
remifentanil, and fentanyl according to their standard practice. The theoretical improvement provided by the
optimization was measured by comparing the time differences between the control predictions and the optimized
prediction of the TROR time and TRON time. In the control group the TROR was 10.2+-5.8 minutes (mean +- SD) and
TRON was 3.5+-5.0 minutes after emergence. In the optimized group the TROR was 7.5+-2.2 minutes or 26% faster (p
< .001, paired t-test) and the TRON was 7.4 +-2.4 minutes or 88% longer (p < .00001, t-test). Optimized
administrations of propofol, remifentanil, and fentanyl resulted in a theoretically shorter emergence time and a
longer period of adequate postoperative analgesia. The optimization algorithm shows potential for real-time
clinical guidance in drug management.

INTRODUCTION
In anesthesia, a rapid emergence time and an adequate period of analgesia are both desired.11
Pharmacokinetic (PK) and pharmacodynamic (PD) modeling and simulation can be used to predict the
anesthetic drug’s effect site concentration (Ce) and the expected probability of response to stimuli.1-6
PK/PD optimization methods take advantage of unique drug characteristics in order to effectively achieve
preferred anesthetic goals. PK model optimization capitalizes on a drug's time course and accumulation
within the body. PD model optimization utilizes the synergistic interaction between sedatives (e.g.,
propofol) and opioids (e.g., remifentanil or fentanyl), which can predict a single probability of effect
given a range of concentrations for the drug combination. For example, the same PD drug effect can be
achieved by decreasing the sedative and increasing the opioid Ce, or vice versa. Combined PK and PD
simulation allows one to explore differing combinations of sedative and opioid Ce and to choose an
optimal combination that best achieves anesthetic goals.
Optimization via PK and PD modeling and simulation has been used in prior research that was
intended to prevent response to surgical stimulation, yet provide an optimal time to emergence upon
termination of the anesthetic.7 Limited infusion durations of 15, 60, 300, and 600 minutes for propofol
and 4 different opioids were explored. Optimal target concentrations identified were largely dependent
on the PD effect and also on the infusion length. Shafer et al. also found the optimal concentrations are
dependent on the infusion history.8 Emergence time was shown to be minimized, but post-operative
pain management requirements were not considered as part of the optimization.
Our motivation was to expand upon prior optimization research by considering both a rapid
wake up and prolonged post-operative analgesia. In some cases, anesthetic goals may compete with one
another (i.e. a rapid emergence versus maintaining adequate analgesia after surgery). The aim of this
study was to develop a cost functional that identifies the best dose of opioids and propofol to meet each
goal while minimizing unwanted prolonged emergence and inadequate analgesia. We hypothesize that
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our optimization algorithm will find optimal infusion rates of propofol, remifentanil, and fentanyl which
will decrease the TROR and extend the TRON without respiratory depression.

METHODS
Overview
The method for optimization was designed as a real time algorithm for anesthesiologists
administering propofol and remifentanil during general anesthesia. The algorithm, without a reduction of
the desired level of sedation and analgesia, suggested changes to propofol and remifentanil infusion
rates that resulted in a more rapid recovery of responsiveness and an increased period of adequate postoperative analgesia. This was accomplished via pharmacokinetic (PK) simulation to calculate effect site
concentration (Ce), and the use of response surface pharmacodynamic (PD) models, which gave a range
of concentration pairs for propofol and opioids maintaining the desired level of effect, see figure 1.

Figure 1 – Algorithm overview

Using a within study design, the potential utility of the optimization algorithm was assessed
using previously collected drug administration data from 21 anesthetics using propofol and remifentanil.6
To evaluate the algorithm, PK and PD simulation were performed twice, once without optimization
(control group) and once with optimization (experimental group). During optimization simulations, PD
effects were maintained at the same level as in each of the control simulations; however propofol and
remifentanil infusion rates were adjusted to achieve a rapid ROR and increased time until RON.
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Modeling
Four compartment pharmacokinetic (PK) models were used to predict the propofol, remifentanil
and fentanyl Ce during the anesthetic. Three response surface pharmacodynamic (PD) models were
used during the optimization process: (I) probability of unconsciousness to assess the level of sedation
during and after the anesthetic (ES), (II) probability of no response to laryngoscopy as a surrogate for
analgesic effect during surgery (EL), and (III) probability of no response to tibial pressure algometry as a
surrogate for analgesia effect during post-operative recovery (EA). 5, 6, 9-13 The pharmacodynamic
response model input is CeR and CeP. Fentanyl Ce (CeF) was converted to CeR using the equivalence
potency ratio of 1:1.2. 6
The response surface models are characterized by the following equation:
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Equation 1 – Greco Pharmacodynamic response surface model
Where E is the probability to effect, EMAX is the maximal possible effect. CeP and CeR are the effect site
propofol and remifentanil concentrations, C50P and C50R are the individual effect site concentrations that
produce 50% of the maximal effect, α is the synergistic interaction between propofol and remifentanil,
and γ is the slope of the response surface curve. E ranges from 0 (0% probability of no response) to 1
(100 % probability of no response). Because these models have been evaluated in a clinical setting, the
models are expressed in terms of the clinically relevant goals: the probability of unconsciousness,
probability of adequate surgical analgesia, and the probability of adequate post-operative analgesia.
Optimization Algorithm
The algorithm behaves as follows:
1. Estimate the remaining time of surgery.
A. To mimic the estimation a clinician would have the algorithm assumed the
remaining surgical time is actual remaining time rounded to the nearest 30
minutes with 20% error.
B. Every 60 minutes during the simulation the algorithm re-evaluates the remaining
time of surgery.
C. 15 minutes prior to the end of surgery the algorithm re-estimates the end of
surgery with 20% error for one last optimization iteration.
2. Estimate the Ce of all anesthetics using the respective PK models.
3. Calculate an opioid CeO (in terms of remifentanil), combining the remifentanil (CeR) and
fentanyl (CeF) effect site concentrations using relative opioid potency relationships (CeO
= CeR + 1.2* CeF)
4. Calculate the PD drug effects using the Ce for propofol and opioids, in terms of the
probability of unconsciousness (ES), probability of no response to laryngoscopy (EL), and
the probability of adequate post-operative analgesia (EA).
5. Starting after induction three different infusions of fentanyl were simulated targeted to
0, 1.5, and 2.5 ng/ml for long term analgesia. In locales where a fentanyl infusion pump
is unavailable (e.g., the U.S.A.), the algorithm suggests alternative dosing intervals of 50
mcg boluses of fentanyl over time to maintain the fentanyl Ce within 20% of the target.
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6. Without reducing the current effects EL or ES, 50 new CeR and CeP pairs are generated for
each of the three fentanyl administrations. This is achieved by choosing a new CeP
ranging from 1.5 mcg/ml to 10 mcg/ml and solving Equation 1 for CeR. To avoid
respiratory depression, if the CeR was greater than 10 ng/ml within 10 minutes of the
end of surgery it was removed from the 50 test Ce pairs.
7. Simulate an effect-site target controlled infusion from the original CeP and CeR to the Ce
values targeted in step 6 for the remainder of the surgery. Simulate the three fentanyl
infusions.
8. Terminate infusions at the end of surgery
9. Calculate the return of responsiveness time (TROR) and return of nociception time (TRON)
times for the simulated infusions.
a. The TROR is the time difference between the time when the infusions are
terminated and the expected emergence.
i. The expected emergence time is determined by the PD probability of
unconsciousness (ES). The average patient emerges at ES = 50%. ES* is
the ES value at the observed ROR during the surgical procedure.
b. The RON time is found by subtracting the time of expected emergence from the
time when the EA falls below 25%.
10. Repeat steps 7-9, targeting a new combination of CeR and CeP values.
11. Given the set of simulated TROR and TRON, use the weighting function with appropriate
weights, equation 2, to determine the best remifentanil and propofol Ce pair (i.e., best
return of responsiveness time given the constraint of adequate analgesia).
a. The weights represent the anesthesiologist priority on sedation and analgesia.
After repeated simulations of this data we found for this data set WROR = 0.85
and WRON = .15 are the best weights.
12. Recommend to the anesthesiologist an infusion rate or a TCI target for remifentanil and
propofol.
13. If the end of surgery has not been reached after 10 minutes, repeat steps 1-12

f (Ce P , Ce F , Ce R ) = w ROR • T ROR (Ce P , Ce F , Ce R )
− w RON • T RON (Ce P , Ce F , Ce R )
Equation 2 – Optimizing weight function
The optimizing weight function is used in step 11. The weighting function minimum determines
the optimal CeP and CeR with the given priorities on sedation and post-operative analgesia. WROR and
WRON are percentages of priority given to sedation and analgesia; however they are kept as variables to
indicate the possibility of altering the priority given to sedation and analgesia. TROR is the forecasted time
until the expected return of responsiveness and TRON is the forecasted time for the expected return of
nociception. The weights WROR and WRON are percentages between 0 and 100 %, the sum of WROR and
WRON are set to 100 %.

4

Algorithm Assessment
Overview
The potential utility of the optimization algorithm was assessed using a PK/PD simulation study
that was based upon clinical data collected from 21 total intravenous general anesthetics using propofol,
remifentanil, and fentanyl using a within-subjects study design.6 The control condition was based upon
model predictions of the anesthetic dosing without any PK/PD optimization. The experimental
conditions were based upon an optimized anesthetic, where the optimization algorithm suggested
changes to propofol and remifentanil infusions were implemented every 10 minutes. A conceptual
“virtual anesthesiologist” always complied with the algorithm’s recommendations. Metrics for
comparison were the TROR and TRON
Clinical Data Set
Data was used from a previous study, where anesthesiologists gave total intravenous general
anesthesia to 21 patients for laparoscopic procedures administering propofol, remifentanil, and
fentanyl.6 In addition, as part of the standard anesthetic technique, a small dose of midazolam was
given pre-operatively. A muscle relaxant (rocuronium) was also administered during induction of
anesthesia and as needed during surgical maintenance. A study investigator was present to record the
patients’ demographics, time and amount of drug administrations, and the time of surgical and
anesthetic events including loss of responsiveness, tracheal intubation, incisions, end of surgery, return
of responsiveness, tracheal extubation, and the start of post-operative care. More patient demographic
information is in table 3, for more details about the procedures we refer you to the work by Johnson et
al.6
Control simulations
For the control simulations, PK and PD simulations on the anesthetics’ dosing scheme were
performed to predict the CeR, CeP, ES, EL, and EA during and after the anesthetic. The patient’s PD level of
sedation, ES*, was set to the ES value at the observed ROR. ES* was calculated in the control group and
used in the experimental group to predict the individual patient’s ROR. ER values were also calculated
for times after surgery.
Experimental simulations
For the experimental simulations, PK and PD calculations were performed in a fashion similar to
the control simulation. However, after tracheal intubation, the optimization algorithm was employed to
recommend changes in the propofol and remifentanil infusion rates every 10 minutes, yet would
maintain the same anesthetic PD effects that were computed in the control condition. A conceptual
“virtual anesthesiologist” complied with the suggested changes provided by the optimization algorithm.
While the optimization algorithm was active, the virtual anesthesiologist maintained WROR and
WRON constant at 0.85 and 0.15 respectively. A wide range of weights were experimented; WROR = 0 to 1
with WRON = 1 to 0 both by increments of .05, only results for the combination WROR = 0.85 and WRON =
0.15 will be presented. The other weights either increased TRON or decreased TROR but were not
significantly different.
Each patient’s optimized anesthetic was assumed to emerge at the same model predicted
probability of ROR as the value observed in the control anesthetic, ES*. The CeR, CeP, ES, EL, and EA were
calculated as the optimized experimental values during and after surgery. Note, the ES and EL are equal
to or greater than the control ES and EL.
This research was to test the viability of an optimization of remifentanil and propofol
administrations; however the fentanyl contribution greatly changes the effect of analgesia. The control
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simulations administered the fentanyl as boluses as administered by the anesthesiologists’. The fentanyl
was administered starting after induction targeted to either 0, 1.5, or 2.5 ng/ml. The average fentanyl
infusion Ce at the end of surgery from the control administered boluses was 1.5 ng/ml with a max at 4
ng/ml.
Metrics and Statistical Analysis
Two metrics were compared between the control and experimental conditions of this simulation
study: the time difference between the end of surgery and the return of responsiveness (TROR), and
secondly, the time difference between the return of responsiveness and the point of inadequate postoperative analgesia as predicted by the PD postoperative analgesia models (TRON). A two-tailed, paired,
student’s t-test (Matlab version, R2008b, Mathworks Inc., MNatick, MA) was used to assess differences
between groups. A p value of 0.05 was considered a statistically significant difference. However, a
Bonferroni correction was applied due to the presence of multiple measures. The ER was calculated for
comparison between the control and experimental group.

RESULTS
Computer simulations were performed on the anesthetic administrations from elective surgeries
for 21 patients. The observed times, patient’s demographics, and the model predicted probability for
sedation at ROR (ES*) for the patients are shown in table 3. Figures 4 and 5 show the control and
optimized simulation experiment for a selected patient #4. Figure 4 has the effect site concentrations
and figure 5 has the model predictions for sedation and post-operative analgesia.

Figure 4 –The two panels
show the effect site
concentrations for the
control and optimized
simulations in solid and
dotted lines respectively
from patient #4. The top
window shows the
remifentanil and fentanyl
effect site concentrations
while the bottom panel
shows the propofol effect
site concentration.
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Figure 5 – Above is shown
the expected PD model
prediction for sedation
and post-surgical analgesia
for both control and
optimized simulations in
solid and dotted lines
respectively from patient
#4. After surgery, this
patient was observed to
regain consciousness
when the probability of
unconsciousness = 20.4%.
The end of surgery, ROR,
and RON times are
displayed on the figure

End of

RON

ROR

Figure 6 shows the difference in times between the control and optimized simulations with
respect to ROR and RON. The control averages and standard deviation are green and the optimized are
in blue. The standard deviations for ROR and RON in both simulations were decreased from the control
simulations. Figure 6 shows the optimized simulation that administered the fentanyl infusion starting
after induction. The standard deviations are decreased with the optimization algorithm, but the major
change is in the average times. The standard deviations for the TROR from control simulations to
optimized simulations were 5.6 minutes to 4.2 minutes and TRON from control simulations to optimized
simulations were 5.8 minutes to 3.4 minutes.
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Figure 6 – The time to ROR
and RON for the control
(green) and the optimized
(blue) groups. The average
(ROR and RON) times are
indicated by the circles; one
standard deviation is shown
by the lines.
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The optimized algorithm decreased ROR time by 2.7+- 2.2 min (p <0.001) and increased the RON
time by 3.9+-2.4 min (p<0.00001). The post-anesthetic respiratory depression (RD) percentages are
listed in table 5 for the control and optimized study conditions. On average the probability of RD
increased from control to optimized anesthetics by a few percent at ROR and extubation times, but at 15
minutes after the end of surgery the RD probability was slightly decreased.
Respiratory Depression
Simulation
RDROR (%)
RD Extubation (%)
RD EOS + 15 min (%)
Control
50.8+-25.5 (5.3 to 96.8) 33.6+- 21.3 (3.6 to 77.0) 23.8+- 17.2 (5.3 to 77.7)
Optimized 52.4+-27.7 (7.4 to 97.0) 34.6+- 24.2 (6.6 to 89.0) 21.8+- 10.0 (5.8 to 45.3)
Table 5 – Respiratory depression listed at the time of extubation as the average +- std dev (minimum value to
maximum value) for the control simulations and the optimized simulations during three different post-anesthetic
points; at the time of ROR, at the time of extubation, and 15 minutes after the end of surgery (EOS).

DISCUSSION
Vuyk et al. found optimal infusions for a rapid return of consciousness. Analgesia was never
addressed in the optimization, but is critical to anesthesia. Interpretation of the results from figure 6
indicates that changing infusions can decrease the TROR and increase the TRON. The improvement of
decreasing TROR is limited by the minimum propofol effect site concentration to maintain sedation intraoperatively and avoid PONV post-operatively.14 The improvement in increasing TRON is limited by the
prohibition to administer sufentanil (a long lasting opioid), high levels of fentanyl, or opioids postoperatively. The results of the optimization did not significantly change the model predicted probability
of respiratory depression.
The results indicate that increasing the remifentanil concentrations and decreasing the propofol
concentrations will result in better post-anesthesia outcomes for both focuses of minimizing ROR and
maximizing RON. The optimization algorithm tended towards higher remifentanil target Ce and lower
propofol Ce because the remifentanil elimination kinetics are very rapid when compared with the
propofol elimination kinetics. The algorithm is based on the PD response model thus the same effect for
sedation and surgical analgesia can be obtained by lowering the propofol Ce and raising the remifentanil
Ce. However adverse side effects may occur, increasing the remifentanil concentrations may induce
respiratory depression13 or decreasing propofol may increase the probability of PONV.15
For our simulation experimented algorithm, we used a single set of weights for WROR = 0.85 and
WRON = 0.15. Real time clinical use of the algorithm might allow the clinician to choose a different
weighting combination to allow for specification in focusing either on decreasing ROR or increasing RON.
In most of the control administrations the anesthesiologists terminated the propofol infusion at
the end of surgery while continuing the remifentanil infusion for 2 to 8 more minutes. We assume this is
to extend the TRON because of the insufficient post-anesthetic analgesic effect. The algorithm was
confined to terminate both infusions at the EOS.
Assumptions
The algorithm is based on the assumption that the current levels of sedation and surgical
analgesia were requisite for that patient during surgery and are respectively quantified by the response
surface models with respect to sedation and laryngoscopy. The PD model is a population based
average and will correctly predict events for very few patients. We do not assert the model prediction
will correctly predict the events; ROR, RON, nor RD. We do assume that the elimination using optimal
administration will be more beneficial to the patient and anesthesiologist. Other variability that was not
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considered was: individual drug tolerance would change the actual C50 values and PD models and
individual cardiac output and blood flow alter the rate constant ke0.16
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